![]()
- 1. Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor.Crystal Growth & Design,2016-07-19.10.1021/acs.cgd.6b00591.
- 2. Suppression of inflammatory responses by dihydromyricetin, a flavonoid from ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways.Journal of Natural Products,2015-07-24.10.1021/acs.jnatprod.5b00275.
- 3. Therapeutic Effects of TianDiJingWan on the Aβ 25-35-Induced Alzheimer's Disease Model Rats.Evid Based Complement Alternat Med.10.1155/2015/307350.
- 4. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways.Life Sciences,2015-06-01.10.1016/j.lfs.2015.03.007.
- 5. Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine.European Journal of Pharmaceutical Sciences,2015-07-10.10.1016/j.ejps.2015.04.001.
- 6. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.Journal of Pharmaceutical and Biomedical Analysis,2015-10-10.10.1016/j.jpba.2015.06.030.
- 7. Tissue Distribution, Excretion, and Metabolic Profile of Dihydromyricetin, a Flavonoid from Vine Tea (Ampelopsis grossedentata) after Oral Administration in Rats.Journal of Agricultural and Food Chemistry,2017-06-14.10.1021/acs.jafc.7b01155.
- 8. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.Biomedical Chromatography,2018-04-01.10.1002/bmc.4156.
- 9. Interactions of Dihydromyricetin, a Flavonoid from Vine Tea (Ampelopsis grossedentata) with Gut Microbiota.Journal of Food Science,2018-05-01.10.1111/1750-3841.14128.
- 10. PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review,2022-03-01.10.1080/07357907.2021.2012188.
